Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 16, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs.

Maria Rita Parisi1, Laura Soldini, Giovanni Di Perri

  • 1Laboratory of Virology, AIDS Center San Luigi, Scientific Institute San Raffaele, Milan, Italy.

The New Microbiologica
|February 5, 2010
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Three settings, one goal: Performance of different HIV testing strategies at a tertiary centre in Milan.

HIV medicine·2026
Same author

Changing Clinical and Laboratory Characteristics of Progressive Multifocal Leukoencephalopathy: A Retrospective National Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy.

AIDS (London, England)·2024
Same author

No need to modify treatment within the first month after rapid start of a tailored antiretroviral therapy: the TWODAY Study.

The new microbiologica·2023
Same author

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.

EClinicalMedicine·2023
Same author

Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimen.

International journal of antimicrobial agents·2023

This study evaluated an oral fluid rapid HIV test, finding it highly sensitive (99.1%) and specific (98.8%). This rapid HIV screening method shows promise for expanding HIV testing and prevention efforts.

Area of Science:

  • Medical Diagnostics
  • Public Health
  • Virology

Background:

  • HIV testing is crucial for screening, early identification, and treatment.
  • Rapid tests and alternative samples like oral fluid can improve consent and access to care.
  • Current HIV screening methods face challenges in certain populations and settings.

Purpose of the Study:

  • To assess the performance characteristics of an oral fluid-based rapid HIV test.
  • To compare the oral fluid rapid test against established HIV testing methods.
  • To evaluate the potential of this rapid test in enhancing HIV prevention strategies.

Main Methods:

  • A comparative study was conducted using an oral fluid rapid HIV test.
  • Performance was evaluated against routine methods in a population with known HIV status (N=875).

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

Related Experiment Videos

Last Updated: Jun 16, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

  • Sensitivity and specificity were calculated, with analysis of discrepant results.

    • Main Results:

    • The oral fluid rapid HIV test demonstrated 99.1% sensitivity and 98.8% specificity.
    • One false negative and five false positive results (faint reactivity) were observed.
    • Excluding three discrepant samples improved specificity to 99.2%.

    Conclusions:

    • Oral fluid rapid HIV tests offer a viable option for HIV screening, potentially increasing access.
    • While performance needs further refinement to minimize errors, these tests can support HIV prevention.
    • The use of rapid tests with alternative samples may expand reach, especially where traditional screening is difficult.